Instruction with the amendments for diagnosis coding of infected wounds was published by the Swedish National Board of Health and Welfare

18

Apr 2018

At the beginning of March, 2018, the National Board of Health and Welfare (Socialtyrelsen) has published the instruction with the amendments for diagnosis coding of infected wounds. The National Board of Health and Welfare (Socialtyrelsen) decided to implement further clarifications:

  • Surgical wound infections (the skin); cellulitis and abscesses of skin and subcutaneous tissues:
    • L02 “Cutaneous abscess, furuncle and carbuncle of face” (skin suppuration, baldness):
      • Description of infection of the superficial layers of skin
    • L03 “Cellulitis” (inflammation of subcutaneous adipose tissue):
      • Description of the inflammation of the skin and subcutaneous layers, including abscess
    • L08.9 “Local infection of skin and subcutaneous tissue, unspecified”:
      • This code should only be used in case of unknown anatomical site of the infection
  • Ulcerations/Chronic wounds:
    • Codes listed above can be used for the description of ulcerations or chronic wounds, however, the following additional codes can be used to clarify the diagnosis:
      • B95 “Streptococcus, group A, as the cause of diseases classified to other chapters” and B96 “Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified to other chapters” - for the description of infectious agents
    • An exception for the coding of ulcerations is precancerous leg ulcers (varicose veins). In these cases, the use of I83.0 “Varicose veins of lower extremities with ulcer” is needed in addition to the wounds coding
  • Post-traumatic Infectious:
    • The diagnosis code T79.3 “Post-traumatic wound infection, not elsewhere classified” should be used as a primary diagnosis code in combination with the codes for skin infections mentioned above and other additional codes according to the exact situation
  • Postoperative wound infections:
    • Typically, the postoperative wound infections are the complications of surgery, which are encoded via the diagnosis codes T80 – T88, however, the varicose veins is an exception, which should be coded via I83.0 “Varicose veins of lower extremities with ulcer”
    • Additional codes should be used in combination with the diagnosis codes T80 – T88 to reflect the specificity of conditions
  • Postoperative wound infections as natural consequences of the disease:
    • In case of intestinal perforation with generalized peritonitis, T-codes should not be used, instead, it is recommended to use codes Y83, Y84

See full description of instruction with the coding examples in Swedish here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

Tags

The latest related news

23

Mar 2022

In late January 2022, Swedish Medical Technologies Product (MTP) Council issued an updated version of recommendations regarding gene expression analysis for decision-making on the adjuvant breast cancer treatment, initially published in November 2021. The recommendation to the regions remains the same. The changes were only concerned with the clarification of some facts.

Read more

16

Mar 2022

In February 2022, Swedish Medical Technologies Product (MTP) Council issued an updated recommendation on FreeStyle Libre for continuous glucose monitoring in type 2 diabetes (T2D). The initial recommendations were published by NT Council in 2018 and updated by MTP Council in 2020 to include FreeStyle Libre 2. In the 2022 update, MTP Council decreased the Hba1c limit from 70 to 60 mmol/mol and added a statement on lifestyle changes and treatment optimization with non-insulin antidiabetic drugs.

Read more

11

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

05

Jan 2022

In December 2021, the Swedish Dental and Pharmaceutical Benefits Agency (TLV) finished the theme survey in the obstructive pulmonary diseases field, which was conducted as a part of the Orderly Introduction for Medical Technologies framework. Identified technologies could potentially be included in the Orderly Introduction of Medical Technologies framework, which aims to facilitate the introduction of novel technologies on the national level.

Read more